Actualizaciones regulatorias
Novedades regulatorias de FDA, EMA, TGA y organismos globales
#baclofen ×
Actualizaciones regulatorias
28 sept 2026•1 min de lectura
FDA Approves Manufacturing Supplements for LIORESAL (baclofen) Tablets
The FDA has approved a series of priority manufacturing (CMC) supplement submissions for the discontinued LIORESAL baclofen tablets (10 mg and 20 mg).
Actualizaciones regulatorias
11 sept 2026•1 min de lectura
FDA Approves ANDA209102 for Generic Baclofen Tablets
The FDA approved ANDA209102 for generic baclofen oral tablets in 5‑20 mg strengths, manufactured by TruPharma, Advagen Pharma and SOLA Pharmaceuticals.